Quick Answer
Dolby Laboratories, Inc. reported R&D Expense of $261.79 million for fiscal year 2025.
Dolby Laboratories, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $261.79M | -0.7% |
| 2024 | $263.66M | -2.9% |
| 2023 | $271.52M | +4.0% |
| 2022 | $261.17M | +3.0% |
| 2021 | $253.64M | +6.1% |
| 2020 | $239.04M | +0.5% |
| 2019 | $237.87M | +0.5% |
| 2018 | $236.79M | +1.5% |
| 2017 | $233.31M | +6.2% |
| 2016 | $219.61M | +9.1% |
| 2015 | $201.32M | +9.9% |
| 2014 | $183.13M | +8.5% |
| 2013 | $168.75M | +20.4% |
| 2012 | $140.14M | +13.1% |
| 2011 | $123.92M | +18.0% |
| 2010 | $104.98M | +28.7% |
| 2009 | $81.54M | +5.2% |
| 2008 | $77.50M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $69.08M | +3.7% | +4.7% |
| June 30, 2025 | $65.98M | +0.7% | +6.9% |
| March 31, 2025 | $61.71M | -1.3% | -7.4% |
| December 31, 2024 | $66.64M | -0.6% | +1.7% |
| June 30, 2024 | $65.50M | -4.7% | +4.8% |
| March 31, 2024 | $62.49M | -8.0% | -6.8% |
| December 31, 2023 | $67.03M | +4.0% | -2.4% |
| June 30, 2023 | $68.70M | +9.3% | +1.1% |
- Dolby Laboratories, Inc. showed a decrease of -0.7% in R&D Expense compared to the prior fiscal year.
- Over the 2008–2025 period, Dolby Laboratories, Inc.’s r&d expense has grown by 237.8% (from $77.50 million to $261.79 million).
- The most recent figure is from Dolby Laboratories, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: